Roche, GSK Say FDA Okays Monthly Osteoporosis Drug (Reuters


Reuters - The U.S. Food and Drug
Administration has approved a monthly version of osteoporosis
drug Boniva, Roche Holding AG and GlaxoSmithKline Plc said on
Friday.

Read more...